Immune-Mediated Inflammatory Diseases and Cancer - a dangerous liaison
Open Access
- 18 September 2024
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1436581
Abstract
Patients with Immune-Mediated Inflammatory Diseases (IMIDs) are known to have an elevated risk of developing cancer, but the exact causative factors remain subject to ongoing debate. This narrative review aims to present the available evidence concerning the intricate relationship between these two conditions. Environmental influences and genetic predisposition lead to a dysregulated immune response resulting in chronic inflammation, which is crucial in the pathogenesis of IMIDs and oncogenic processes. Mechanisms such as the inflammatory microenvironment, aberrant intercellular communication due to abnormal cytokine levels, excessive reparative responses, and pathological angiogenesis are involved. The chronic immunosuppression resulting from IMIDs treatments further adds to the complexity of the pathogenic scenario. In conclusion, this review highlights critical gaps in the current literature, suggesting potential avenues for future research. The intricate interplay between IMIDs and cancer necessitates more investigation to deepen our understanding and improve patient management.Keywords
This publication has 209 references indexed in Scilit:
- Daily Insulin Dose and Cancer Risk Among Patients With Type 1 DiabetesJAMA Oncology, 2022
- Effect of Costimulatory Blockade With Abatacept After Ustekinumab Withdrawal in Patients With Moderate to Severe Plaque PsoriasisJAMA Dermatology, 2021
- Prevalence, Incidence, and Risk of Cancer in Patients With Psoriasis and Psoriatic ArthritisJAMA Dermatology, 2020
- Brief Report: Anti–RNPC‐3 Antibodies As a Marker of Cancer‐Associated SclerodermaArthritis & Rheumatology, 2017
- Review: Cancer‐Induced Autoimmunity in the Rheumatic DiseasesArthritis & Rheumatology, 2015
- Most Patients With Cancer‐Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP‐2 or Transcription Intermediary Factor 1γArthritis & Rheumatism, 2013
- Cancer Incidence in Systemic Sclerosis: Meta‐Analysis of Population‐Based Cohort StudiesArthritis & Rheumatism, 2013
- Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexateArthritis Care & Research, 2008
- Significance and detection of dysplasia in chronic colitisCancer, 1996
- Cancer in systemic sclerosisArthritis & Rheumatism, 1993